Extracellular vesicles contain a lipid bilayer membrane that protects the encapsulated
material, such as proteins, nucleic acids, lipids and metabolites, from the extracellular …

Extracellular vesicles (EVs) are a heterogeneous group of natural particles that are relevant
to the treatment of cardiovascular diseases. These endogenous vesicles have certain …

The low yield of extracellular vesicle (EV) secretion is a major obstacle for mass production
and limits their potential for clinical applications as a drug delivery platform. Here, we mass …

The utilization of extracellular vesicles (EVs) in clinical theranostics has rapidly advanced in
the past decade. In November 2018, the International Society for Extracellular Vesicles …

An important aspect in the development of extracellular vesicle (EV) therapeutics is
identifying and quantifying the key features defining their identity, purity, sterility, potency …

Exosomes are extracellular vesicles with a diameter of 30–100 nm that exist stably in
various body fluids, including the blood, cerebrospinal fluid, urine, saliva, and serous cavity …

The extracellular vesicles (EVs) released by plant pathogens of the Pectobacterium genus
were investigated. The isolates were obtained using differential centrifugation followed by …

The field of regenerative medicine has expanded greatly in the past decade, with more than
1000 current clinical trials involving mesenchymal stromal cell (MSC) treatment. Multiple …

Repairing the damaged blood-CNS-barrier in amyotrophic lateral sclerosis (ALS) is
necessary to prevent entry of detrimental blood-borne factors contributing to motor neuron …

Despite significant efforts made to treat cardiovascular disease (CVD), more than half of
cardiovascular events still occur in asymptomatic subjects devoid of traditional risk factors …